Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-26 Sale | 2024-06-27 8:00 pm | KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS | 4,653 | $4.75 | $22,102 | 83,041 (Indirect Direct) | View |
| 2024-05-31 Sale | 2024-06-03 8:00 pm | KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS | 2,093 | $6.09 | $12,746 | 87,694 (Indirect Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:03 pm | KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS | 1,405 | $6.74 | $9,470 | 119,087 (Indirect Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 62 | $28.54 | $1,769 | 14,836 (Indirect Direct) | View |
| 2022-10-26 Sale | 2022-10-28 4:15 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 214 | $6.51 | $1,393 | 2,098 (Indirect Direct) | View |
| 2022-06-27 Sale | 2022-06-29 8:10 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 3,092 | $0.37 | $1,144 | 115,541 (Indirect Direct) | View |
| 2022-01-04 Sale | 2022-01-05 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 3,454 | $1.3 | $4,490 | 356,633 (Indirect Direct) | View |
| 2021-10-26 Sale | 2021-10-28 8:03 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd CHIEF OPERATING OFFICER | 12,544 | $1.8 | $22,579 | 122,087 (Indirect Direct) | View |
| 2021-06-28 Sale | 2021-06-29 5:25 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd CHIEF OPERATING OFFICER | 2,911 | $5.77 | $16,796 | 134,631 (Indirect Direct) | View |
| 2020-06-05 Purchase | 2020-10-28 8:36 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer | 42 | $7.8757 | $331 | 110,042 (Indirect Direct) | View |
| 2020-03-16 Purchase | 2020-03-17 5:46 pm | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer | 10,000 | $5.75 | $57,500 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-05 4:03 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS | 35,800 | $0 | 119,087 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 113,629 | $0 | 149,623 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2027-11-19 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 21,158 | $0 | 35,994 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 21,158 | $0 | 35,994 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 576 | $0 | 576 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 4:05 pm | N/A 2033-01-26 | Pulmatrix Inc. | PULM | Bazemore Todd Director | 1,700 | $0 | 1,700 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 12,800 | $0 | 14,836 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-28 8:44 pm | N/A 2032-01-27 | Pulmatrix Inc. | PULM | Bazemore Todd Director | 22,100 | $0 | 22,100 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS | 238,000 | $0 | 356,633 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 9:45 pm | N/A 2031-01-28 | Pulmatrix Inc. | PULM | Bazemore Todd Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 4:53 pm | N/A 2031-01-03 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer | 137,500 | $0 | 247,542 (Direct) | View |
| 2020-10-26 Option Award | 2020-10-28 8:36 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer | 81,000 | $0 | 110,042 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 4:15 pm | N/A 2030-10-01 | Pulmatrix Inc. | PULM | Bazemore Todd Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:25 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer | 19,000 | $0 | 29,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:12 pm | N/A 2030-01-01 | Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer | 120,000 | $0 | 120,000 (Direct) | View |